A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids
David C. Currow, Katherine Clark, Sandra Louw, Belinda Fazekas, Aine Greene, Christine R. Sanderson
Research output: Contribution to journal › Article › peer-review
11Citations
(Scopus)
Fingerprint
Dive into the research topics of 'A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids'. Together they form a unique fingerprint.